{"name":"4Moving Biotech","slug":"4moving-biotech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"4P004","genericName":"4P004","slug":"4p004","indication":"Other","status":"phase_2"},{"name":"4P-004","genericName":"4P-004","slug":"4p-004","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"4P004","genericName":"4P004","slug":"4p004","phase":"phase_2","mechanism":"4P004 is a small molecule that targets the [unknown molecular target] to treat [unknown therapeutic area].","indications":[],"catalyst":""},{"name":"4P-004","genericName":"4P-004","slug":"4p-004","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNXpMcFV0alp4d0R1b0hzam5vQmx2YkFLRkRYX1lEMTZGTzVsM0g0UE5BdUVCVjJBRFZ5S1Q0WnQ1N1ZjTVFLM3hzeHh1dnZiOU81MUJ0N2YzM0dyX0I4SDRSdHUtV01pel9NM05DUU95RXM3eFJjUU1hMG9WaWR5WEVBalV5Zmo4X0Z5Tmo5OXNJbDdnV0N1NW1xS1F4bEk2bHlaZG12dVA0Y0hHdkVDVEo0RWNtRTFKSWd6Y1hCNnhxYTlrNEJCV0VpdXdBNzhUdUVNZ20ycGpHUlFZdzBRc1NwZkF4WkFJc0JWQVA0WEY2QQ?oc=5","date":"2026-02-10","type":"pipeline","source":"BioSpace","summary":"4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthritis - BioSpace","headline":"4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthriti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBYSWN2M012YXBFbVh1TmlYaWo5SGZFb0VEUl9YWTJWRV90RkVPVE5xaUN3UXV0enM1alAwa1IxMllIMkRkeXRzT1R2WlJJRTF4SmgwVnB4N1I?oc=5","date":"2026-02-10","type":"pipeline","source":"afp.com","summary":"4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthritis - afp.com","headline":"4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthriti","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-10","type":"trial","source":"Pulse 2.0","summary":"4Moving Biotech Closes €12 Million Financing To Push Knee Osteoarthritis Drug Toward Phase 2a Proof Of Concept - Pulse 2.0","headline":"4Moving Biotech Closes €12 Million Financing To Push Knee Osteoarthritis Drug Toward Phase 2a Proof Of Concept - Pulse 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPQU5zbmdVcHE3QmtpWnpfU05CUHduS3BSNENPdzFIVTRxa050eDJncEd1akl4MmtIOUdOa1E5OWdxaURRVVNRVTdaSFRIYmlHYTdWa2JGYXZNZDhlTElnY3VmQ3ZTVXJwOTZQc3UxNzZMMUZvSzdrVDJQR2NwdkI2UkdNbGxmamE5M0Vfd3N6VWhxM2VVclczTXlxZDJabUlYcG1UdUdUdml5aTFzREI4N0tZSkxrODVFRXVMeEpSMFFRMjVmQUlLV1FTc1JUNV9CTmw1c1FPLXVuRFdzbjYydUlKbkFqUmthZ0FVclJsMnoyUk9HNTFSaWwxZGhSdw?oc=5","date":"2025-07-16","type":"trial","source":"BioSpace","summary":"4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis - BioSpace","headline":"4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Oste","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOenc4YjZVOThyNUo5M2JkeGs2NEJjWVRlSllfZ19OWlFwUlQwVU1fc2xBaW5Bd3RyMTJVdkpaWURiR3FiVXVZX3NnNEI0d0VjVFd5eWVxVG1NWm5DWGxtWEdHSVlXbDlPRWNrXzFGWUROSGp0djdnUDhWM2d5U0k5SWV3WkpXY0RZRURxcnJ3R3JWLXZNaEpOZXh1UERqZjlaRTRNVWQ3NlNSVVRpVTVHdnItSXB4b0ZYTVljUHJaVThQeUl5V2dwbDZ4M3JaTWpaNW1USXU1eGNzRGYwQUJWZjFSR25TV2pvd1cwMFV4b0loSWduR2ZXY0NIeExhdkRqb3JFN0VCRDVwREhn?oc=5","date":"2025-04-08","type":"pipeline","source":"Business Wire","summary":"4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis Drug - Business Wire","headline":"4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPRjVqd3EwVjFDNTg4cWRxTXF5YU1xSEZJZTl0NkVyd1E4eTVuczAtLWtKcDFPZnpBR1NZczRxUGhrZ2hkUmE0V2k0WTZod2RQUjhzSDVSWlNtT3BnczRYNEF2a3h4MkJkclNId2lCVG1MYTlzTG5VU3pEbklqZzd5Q005U29NZUZFSVJJQW9GcVhnVDZHZUtoZ0xPZ1Awc2NkX0QwSWZGZmEwVnk3RkxhNjM0OUVDeFQwZUFpZ0xXX2UwU1FhRmI1N05UQ0ppT2ZtSXVHbllmdEhFQWZ0Q1RfTU1KZ1cxYkZSTDYwUlZNZ1JCOE5RdF9WbFpVTFVkZw?oc=5","date":"2025-03-27","type":"trial","source":"Business Wire","summary":"Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis - Business Wire","headline":"Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOblkxaHM5MDQxSDctQ05xYm00aUM2aDhEa0tsZzFzZzVyRnppdV9oSElPN255UW9NZGhrSjdkaElDQXhfMlJScEZFMS1SZ1RITnJUQmdFOVluWmY0a3lTSmZ6OGpYRDY3THRoOEkxYmNESTVCYUV1RjhsbnFjeHNYMDBtc3c3LVRwQ1VvZGxPbFpmc3lVaFJFNlVySENzWWNPWHAzQWFsRi1iUlJhRWQ5aUxCN0FROWx4SU45WWZ3Ti1SOHJvNVRIY1NTWDdhcVc0RHk3TmpsLUliQllHbVpNdF9R?oc=5","date":"2024-07-02","type":"trial","source":"Business Wire","summary":"4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth - Business Wire","headline":"4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxQS3Z6dVFwMnUyemEzOUNqT2NQUDJaZHpOZFIyZWZCNFhKYXFYRmhNNUVZc1QzaFBkb3Uxb0ZSUVozQy1UTlhtSEpSc3NsOEo5czFUNml3NGJadjV3N3hRZ1JnVERiVVFBanhJX1JwV05vamJ6Y04yR2JkblRQX1VVVDJiRURXWXBldGljTlZUTDM4ZXlacWw5RzlYdmpLNHUzTEhYUndEQ3BiSUpGWHBrQ1FDbW96VUJoaTl2X1ZGdXphc25ZX0dZdmwzbGlwLVhXYVpJLURpTTJtZFBtN3Z1dzVoc2NSZ0h4eHpxMW5LYlNsQnJINFR1OTV3SVVHVTUxVFMtZA?oc=5","date":"2024-06-10","type":"trial","source":"BioSpace","summary":"4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients - BioSpace","headline":"4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNWnZCbXhUaTJ1SmRuSktqWFhyOVJRUkllV1l2ZnN3N09TZGxQOHNNUllFWVNjU3hpcFY5RkJ2NHMycl9Oa2l2bnVHenc3R0pNTWppRFo5eV9fM0pLNE5jV1J5QV9TT1dhQTBZSjJ0dEpUU1k4QzNwX3hncXlEZnRBUzBOVS1KU2ZTc2J0ZmNrNWRlZkdSWHFLSVhHVGJXak41UHJ4R3p2OWZCaUdJcmh5Rk9DdDl1dWozX09YZV9SckI3Q2I5bFBoZm1ybFI5V25jNDhmOHFqMm96QnJMWU5XWFBNMm0xVXVGa2c?oc=5","date":"2023-11-10","type":"pipeline","source":"Business Wire","summary":"4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts - Business Wire","headline":"4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPVFl0c1BReGpIS2gtRDBXWGQzY1ZYZ3lncC1rVGdGTTM5bVpQdU1CaW0zdzVzckJKZ1NSWFBwakh4QnJsdGltdE5VQ0dTTHpKUjFpczFVdlU1bUkzQWxwa0R5VGt1TEFFNXZ5XzVILWxCWDhiWXJ4eG1lNkdyLVQ4X1RGc0loSlgtc3Ayb1RMdTdHYXRpR05ZZG1zSW9HR2k1cGxINkhlRm1OVVVmRmZFX1ZobWEzM0JmQXJBdFNjZHhGR3FvNl9GRWd0aDBBQQ?oc=5","date":"2023-10-19","type":"trial","source":"BioSpace","summary":"4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis - BioSpace","headline":"4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}